Suppression of thyroglobulin secretion in amiodarone iodine-induced thyrotoxicosis.
A 41-year-old male patient developed amiodarone-induced thyrotoxicosis after 29 months of treatment with amiodarone. Thyrotoxicosis was readily reversible after cessation of the drug and did not need specific thyrostatic treatment. In contrast to what was expected, thyroglobulin serum concentrations, that were normal during the first 2 yr of follow up, decreased drastically to undetectable levels during and after the thyrotoxic phase. Although no explanation can be offered for this phenomenon, it seems important to point out the fact that measurement of thyroglobulin is of only limited value in the diagnosis of thyroid dysfunction in patients treated with amiodarone. Low levels do not exclude thyrotoxicosis.
Weissel
M
M
Second Department of Medicine University of Vienna, Austria.
D000328:Adult; D000638:Amiodarone / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D013954:Thyroglobulin / Q000097:blood / Q000378:metabolism*; D013971:Thyrotoxicosis / Q000139:chemically induced*; D014693:Ventricular Fibrillation / Q000188:drug therapy
D013954:Thyroglobulin; D000638:Amiodarone